Increasing uptake of lung cancer screening in individuals at high risk of lung cancer

Not Applicable

Completed

• Conditions: Cancer; Topic: Cancer; Subtopic: Lung Cancer; Disease: Lung (small cell); Small cell lung cancer

• Registration Number: ISRCTN21774741
• Lead Sponsor: niversity College London Biomedical Research Unit

Brief Summary

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27098676 protocol 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31558626/ cardiovascular risk results (added 27/05/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33087548/ psychological burden results (added 23/10/2020) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31082267/ Substudy results (added 10/10/2023) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/32164439/ Substudy results (added 10/10/2023) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35567604/ Substudy results (added 10/10/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32759387/ nodule and cancer outcomes (added 10/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-09-23
• Study Completion: 2019-12-31
• Last Update Posted: 23 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1005

Inclusion Criteria

1. Aged 60 to 75 years
2. Recorded as a current smoker from 2010 or later

Exclusion Criteria

1. Active diagnosis of lung cancer or metastases
2. CT thorax within the past year
3. Inability to consent to study
4. Palliative care register
5. GP's alert to co-morbidity that contraindicates screening or treatment for lung cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Attendance to lung health check measured approximately 2 weeks post receipt of invitation